Cortechs.ai | NeuroQuant PET

Rapid, automated subregional tracer quantification

Our research-specific component of NeuroQuant® provides researchers and physicians with a cutting-edge tool for the study of frontotemporal dementia and Alzheimer’s disease.

Cortechs.ai|NeuroQuant PET
Cortechs.ai|NeuroQuant PET
Cortechs.ai|NeuroQuant PET

Insight that leads to breakthrough discoveries

Automatically quantify PET tracer bindings localized to brain structures identified by NeuroQuant® 3D T1 MRI segmentation. Select between two tracers for metabolic (FDG) and amyloid-based (Florbetapir) analysis and compare visual and statistical (Z-score) comparisons of each normalized regional PET tracer value to normative population data.

Benefits

Cortechs.ai|NeuroQuant PET

Reporting options

Choice of reports corresponding to PET tracer used

Cortechs.ai|NeuroQuant PET

Clear visualization

Color-coded, graphical reports simplify quantitative reads

Cortechs.ai|NeuroQuant PET

24/7 access

Secure access to Cortechs.ai’s secure, cloud-based system from virtually anywhere

NeuroQuant® PET reports

Powered by NeuroQuant® for trusted and proven brain segmentation analysis.

Related insights

06/16/2025

Seeing Alzheimer’s More Clearly: How PET Imaging Is Changing the Game

PET imaging is transforming how we detect and monitor Alzheimer’s disease, enabling earlier diagnosis, better disease tracking, and more personalized treatment.

12/13/2018

Cortechs.ai receives multi-year million dollar grant for the diagnosis and prediction of Alzheimer’s disease using PET image analysis

07/06/2016

The Importance of Image Alignment for Multimodal Volumetrics

Scroll to Top